A pilot trial of dextromethorphan in amyotrophic lateral sclerosis.
Assuming the presence of glutamate-induced neurotoxicity in amyotrophic lateral sclerosis 14 patients were treated with dextromethorphan, an N-methyl-D-aspartate receptor antagonist. The patients were treated with 150 mg dextromethorphan or placebo daily for 12 weeks in a double-blind crossover tria...
Na minha lista:
| Publicado no: | J Neurol Neurosurg Psychiatry |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1014822/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8437010/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.56.2.197 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|